Infections are a growing global threat, and the number of resistant species of microbial
pathogens is alarming. However, the rapid development of cross-resistant or multidrug …

Objective: Serotonin reuptake inhibitors are the predominant treatment for major depressive
disorder. In recent years, the diversity of the gut microbiota has emerged to play a significant …

Over the past decade, there has been increasing evidence highlighting the implication of the
gut microbiota in a variety of brain disorders such as depression, anxiety, and …

Relationship between drugs and microbiota is bilateral. Proper composition thus function of
microbiota is a key to some medications used in modern medicine. However, there is also …

Multidrug resistance (MDR) is a major obstacle in the therapy of infectious diseases and
cancer. One of the major mechanisms of MDR is the overexpression of efflux pumps (EPs) …

The global spread of microbial resistance coupled with high costs and slow pace in the
discovery of a new antibiotic have made drug repositioning an attractive and promising …

Currently, there is little published data on the effects of antidepressants on normal gut
microbiota and the consequences of such effects on treatment outcomes. The aim of the …

Atopic Dermatitis (AD) skin is susceptible to Staphylococcus aureus (SA) infection,
potentially exposing it to a plethora of toxins and virulent determinants, including Panton …

Selective serotonin reuptake inhibitors (SSRIs) are used to treat affective and anxiety
disorders. Antidepressants have also been shown to have antimicrobial and …

Emerging evidence highlighted the essential role played by the microbiota-gut-brain axis in
maintaining human homeostasis, including nutrition, immunity, and metabolism. Much …